Developer docs
API playgroundTry for free, no card

Search company profiles

DNASense

Full company profile

uuid000ju33

Namestring
DNASense
Legal namestring
DNASense
Websiteurl
dnasense.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

DNASense, founded in 2014 in Aalborg, Denmark, is a microbial analysis company built on DNA sequencing that delivers microbiome and multi-omics research services to academic, clinical, and commercial customers. Following its merger with Clinical Microbiomics, CosmosID, and MS-Omics into the consolidated entity Cmbio, DNASense operates as part of a platform-plus-services organization with regional headquarters in Copenhagen and Germantown, Maryland, and claimed reach across the US, EU, and APAC.

The company's underlying technology is an integrated multi-omics platform spanning shotgun and long-read metagenomics, metabolomics, metatranscriptomics and transcriptomics, proteomics and metaproteomics, marker gene and 16S analysis, plus the cloud-based Cosmos-HUB bioinformatics platform. Service offerings are organized around human health (gut, vaginal, oral, skin, infant, neurology, immuno-oncology, infectious disease/AMR, clinical trials), animal and environmental health (eDNA, AMR surveillance, agriculture, aquaculture, wastewater, soil), and a bioinformatics layer that includes biostatistics, integrative multi-omics, strain tracking and engraftment, and machine learning/AI services.

DNASense monetizes through quote-based, multi-year professional services engagements — laboratory sequencing, custom kitting, and bioinformatics support — alongside a self-serve software channel via Cosmos-HUB. Go-to-market is sales-led with content marketing (insights blog, publications, case studies, webinars) feeding top-of-funnel awareness and direct scientist engagement closing mid- and bottom-of-funnel deals. Marquee relationships include MD Anderson Cancer Center, Brigham and Women's Hospital, Microbiome Labs (co-development), and Resilient Biotics. No revenue, funding, or ownership disclosures are available.

Short descriptiontext

DNASense is a Danish DNA-sequencing-based microbial analysis company that, through its merger into Cmbio, provides end-to-end multi-omics research services and the Cosmos-HUB bioinformatics platform to academic, clinical, and science-driven commercial customers worldwide.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAalborg, Denmark
HQ citystring
Aalborg
HQ countrystring
Denmark
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
microbiome research services, multi-omics analysis, DNA sequencing services, bioinformatics platforms, microbial analysis
Industry5 codes
PRIMARYHLAGANAH
Microbiome & Metagenomics Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAAAFAI
Microbiome Analytics, Sequencing & Bioinformatics Platforms
SECONDARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
NAICS code2 codes
  • Medical Laboratories621511
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Services-Medical Laboratories8071
  • Services-Commercial Physical & Biological Research8731
Product category
Microbiome and Multi-Omics Research Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Laboratory Services
TypeProfessional Services
Description

Providing multi-omics sequencing and analysis services to researchers and science-driven companies

cmbio.io
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Custom service engagement
ModelOtherBilling cadenceMulti-year contract
Notes

Tailored to specific research requirements; direct collaboration with specialized scientists for guidance on analytical techniques and method selection

cmbio.io
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

DNASense provides end-to-end microbiome and multi-omics research services built on DNA sequencing, including shotgun and long-read metagenomics, microbial strain characterization, metabolomics, metatranscriptomics, and proteomics. The company complements laboratory services with the Cosmos-HUB cloud-based bioinformatics platform and AI-driven data analysis for researchers and science-driven companies in human health, animal health, and environmental applications.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Minimizing false positives through robust pipelines and quality controls
+1 more record
Product overview1 text field

Cmbio is a multiomics research services company formed through the fusion of Clinical Microbiomics, CosmosID, DNASense, and MS-Omics. The company operates as a platform-plus-services model, offering end-to-end microbiome research services including: Cosmos-Hub (cloud-based bioinformatics platform for data analysis), shotgun and long-read metagenomics sequencing, microbial strain characterization, metabolomics, metatranscriptomics/transcriptomics, proteomics, biostatistics, integrative systems biology and multi-omics integration, strain tracking, machine learning/AI services, and sampling kits. Services span human health (gut, vaginal, oral, skin, infant microbiome; neurology/mental health; cancer/immuno-oncology; infectious diseases), animal health (aquaculture, agriculture, companion animals), and environmental health (eDNA metabarcoding, wastewater, soil health, production safety).

Product and service18 records
1Cosmos-HUB
CategorySoftware Platform
Description

Cloud-based bioinformatics platform for microbiome data analysis used by research teams to conduct their own bioinformatic and analytic support for clinical and research questions.

2Shotgun Metagenomics
CategorySequencing Service
Description

Untargeted metagenomic sequencing service that sequences all DNA in a sample to provide high-resolution microbiome analysis across multiple species in complex microbial communities, enabling precise detection of microbial species, functional potential, antimicrobial resistance, and virulence factors.

3Long-Read Metagenomics
CategorySequencing Service
Description

Long-read sequencing service for building complete microbial genomes and achieving comprehensive taxonomic and functional analysis.

4Microbial Strain Characterization
CategorySequencing Service
Description

Fast and affordable microbial strain characterization services to explore microbial diversity, functionality, and applications with regulatory report generation.

5Marker Gene Analysis
CategorySequencing Service
Description

Sequencing service for analyzing specific marker genes in microbial communities.

6Microbiome Profiling
CategorySequencing Service
Description

Service for profiling the taxonomic composition of microbial communities.

7Absolute Abundance
CategorySequencing Service
Description

Quantitative microbiome profiling service for measuring the absolute abundance of microbial taxa.

8Direct-to-Consumer Testing
CategorySequencing Service
Description

Consumer-facing microbiome testing services that provide personalized health insights.

9Metabolomics Services
CategorySequencing Service
Description

Comprehensive metabolomics services including both untargeted and targeted metabolomics analyses, integrated with metagenomics and other omics data to reveal functional potential and health outcomes.

10Metatranscriptomics and Transcriptomics Services
CategorySequencing Service
Description

RNA sequencing services for gene expression profiling, active metabolic pathway discovery, and understanding microbial responses under various conditions.

11Proteomics Services
CategorySequencing Service
Description

Protein analysis services supporting microbiome research.

12Metaproteomics
CategorySequencing Service
Description

Service for analyzing protein expression in complex microbial communities.

13Bacterial Genome Sequencing
CategorySequencing Service
Description

16S rRNA sequencing service for accurate bacterial identification.

14Sampling Kits and Project Handling
CategoryService
Description

Custom kits and project handling for efficient microbiome sample collection, preservation, and transport, tailored to study needs and global logistics.

15Biostatistics
CategoryBioinformatics Service
Description

Statistical analysis services for microbiome and multi-omics research data.

16Integrative Systems Biology and Multi-omics Services
CategoryBioinformatics Service
Description

Integrative analysis combining multi-omics data (metagenomics, metabolomics, transcriptomics, proteomics, epigenomics) with advanced bioinformatics to deliver actionable insights.

17Strain Tracking and Engraftment
CategoryBioinformatics Service
Description

Service for tracking microbial strains and monitoring engraftment in microbiome studies.

18Machine Learning and AI Services
CategoryBioinformatics Service
Description

AI-powered bioinformatics services for analyzing complex microbiome and multi-omics data.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

CosmosID is one of the four entities (along with Clinical Microbiomics, DNASense, and MS-Omics) that fused to form Cmbio, creating a comprehensive multi-omics research platform. CosmosID contributed its microbiome analysis expertise and Cosmos-HUB bioinformatics platform.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

CosmosID is one of the four entities that merged to form Cmbio, and its Cosmos-HUB bioinformatics platform is now a core Cmbio asset. As a historical independent, it was a direct competitor in microbiome analytics and bioinformatics software.

2Second Genome
TypeEmerging player
Description

Second Genome applies microbiome sciences to drug discovery, with both discovery services and therapeutic programs. Comparable to Cmbio's translational microbiome services business, though it sits further down the value chain toward therapeutics.

TypeDirect peer
Description

Zymo Research provides both microbiome kits/consumables and a microbiome sequencing services arm (ZymoBIOMICS), competing directly with Cmbio on sample collection, sequencing, and bioinformatics. Overlapping product/service model and customer segments.

TypeEmerging player
Description

DNAnexus provides cloud-based bioinformatics platforms for multi-omics data analysis, including microbiome and clinical genomics. Comparable to Cosmos-HUB as a cloud bioinformatics layer serving research and clinical customers.

5Clinical Microbiomics
TypeDirect peer
Description

Clinical Microbiomics (now part of Cmbio) was a direct peer in clinical microbiome sequencing and bioinformatics services, especially for pharma and translational research clients. Pre-merger overlap with DNASense in human health microbiome work.

TypeDirect peer
Description

RTL Genomics (a LGC Group company) provides next-generation sequencing and bioinformatics services for microbiome, environmental, and agricultural research. Directly comparable specialty lab services model and end markets.

TypeDirect peer
Description

MR DNA (Molecular Research LP) is a contract genomics lab offering 16S, shotgun metagenomics, and bioinformatics for environmental and human microbiome studies. Competes with Cmbio on price-sensitive academic and environmental microbiome projects.

TypeBroad incumbent
Description

Qiagen offers broad bioinformatics platforms (CLC Genomics Workbench) and microbiome sample-to-insight workflows that overlap with Cosmos-HUB. Larger incumbent with broader portfolio but less specialized in pure microbiome services.

9Diversigen (Eurofins)
TypeDirect peer
Description

Diversigen, now part of Eurofins, is one of the closest direct competitors, offering shotgun metagenomics, 16S, and targeted microbiome sequencing services to academic and pharma clients globally. Highly comparable services portfolio and customer base to DNASense/Cmbio.

10MS-Omics
TypeDirect peer
Description

MS-Omics (now part of Cmbio) specialized in mass spectrometry-based metabolomics and proteomics services. Pre-merger it was a direct peer in the metabolomics leg of Cmbio's multi-omics offering.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

DNASense

Microbiome and Multi-Omics Research Servicesdnasense.com

DNASense is a Danish DNA-sequencing-based microbial analysis company that, through its merger into Cmbio, provides end-to-end multi-omics research services and the Cosmos-HUB bioinformatics platform to academic, clinical, and science-driven commercial customers worldwide.

What DNASense does

DNASense, founded in 2014 in Aalborg, Denmark, is a microbial analysis company built on DNA sequencing that delivers microbiome and multi-omics research services to academic, clinical, and commercial customers. Following its merger with Clinical Microbiomics, CosmosID, and MS-Omics into the consolidated entity Cmbio, DNASense operates as part of a platform-plus-services organization with regional headquarters in Copenhagen and Germantown, Maryland, and claimed reach across the US, EU, and APAC.

The company's underlying technology is an integrated multi-omics platform spanning shotgun and long-read metagenomics, metabolomics, metatranscriptomics and transcriptomics, proteomics and metaproteomics, marker gene and 16S analysis, plus the cloud-based Cosmos-HUB bioinformatics platform. Service offerings are organized around human health (gut, vaginal, oral, skin, infant, neurology, immuno-oncology, infectious disease/AMR, clinical trials), animal and environmental health (eDNA, AMR surveillance, agriculture, aquaculture, wastewater, soil), and a bioinformatics layer that includes biostatistics, integrative multi-omics, strain tracking and engraftment, and machine learning/AI services.

DNASense monetizes through quote-based, multi-year professional services engagements — laboratory sequencing, custom kitting, and bioinformatics support — alongside a self-serve software channel via Cosmos-HUB. Go-to-market is sales-led with content marketing (insights blog, publications, case studies, webinars) feeding top-of-funnel awareness and direct scientist engagement closing mid- and bottom-of-funnel deals. Marquee relationships include MD Anderson Cancer Center, Brigham and Women's Hospital, Microbiome Labs (co-development), and Resilient Biotics. No revenue, funding, or ownership disclosures are available.

DNASense firmographics

Firmographics
Name
DNASense
Legal name
DNASense
Website
https://dnasense.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
11–50 employees
Short description
DNASense is a Danish DNA-sequencing-based microbial analysis company that, through its merger into Cmbio, provides end-to-end multi-omics research services and the Cosmos-HUB bioinformatics platform to academic, clinical, and science-driven commercial customers worldwide.
Ownership category
akta.pro rank

DNASense industry classification

Industry
Product category
Microbiome and Multi-Omics Research Services
NAICS
Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGANAH
Microbiome & Metagenomics Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAAAFAI
Microbiome Analytics, Sequencing & Bioinformatics Platforms
SECONDARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)

Keywords

  • Microbiome research services
  • Multi-omics analysis
  • DNA sequencing services
  • Bioinformatics platforms
  • Microbial analysis

Where DNASense is headquartered

Location

Headquarters

HQ city
Aalborg
HQ country
Denmark
HQ region
Europe

Offices2 records

Markets served

DNASense business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Laboratory Services: Providing multi-omics sequencing and analysis services to researchers and science-driven companies

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom service engagement

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

DNASense product offering

Product offering

Core offering

DNASense provides end-to-end microbiome and multi-omics research services built on DNA sequencing, including shotgun and long-read metagenomics, microbial strain characterization, metabolomics, metatranscriptomics, and proteomics. The company complements laboratory services with the Cosmos-HUB cloud-based bioinformatics platform and AI-driven data analysis for researchers and science-driven companies in human health, animal health, and environmental applications.

Product overview

Cmbio is a multiomics research services company formed through the fusion of Clinical Microbiomics, CosmosID, DNASense, and MS-Omics. The company operates as a platform-plus-services model, offering end-to-end microbiome research services including: Cosmos-Hub (cloud-based bioinformatics platform for data analysis), shotgun and long-read metagenomics sequencing, microbial strain characterization, metabolomics, metatranscriptomics/transcriptomics, proteomics, biostatistics, integrative systems biology and multi-omics integration, strain tracking, machine learning/AI services, and sampling kits. Services span human health (gut, vaginal, oral, skin, infant microbiome; neurology/mental health; cancer/immuno-oncology; infectious diseases), animal health (aquaculture, agriculture, companion animals), and environmental health (eDNA metabarcoding, wastewater, soil health, production safety).

Differentiator

Problem solved

Functional benefit

Products and services

  • Cosmos-HUB Cloud-based bioinformatics platform for microbiome data analysis used by research teams to conduct their own bioinformatic and analytic support for clinical and research questions.
  • Shotgun Metagenomics Untargeted metagenomic sequencing service that sequences all DNA in a sample to provide high-resolution microbiome analysis across multiple species in complex microbial communities, enabling precise detection of microbial species, functional potential, antimicrobial resistance, and virulence factors.
  • Long-Read Metagenomics Long-read sequencing service for building complete microbial genomes and achieving comprehensive taxonomic and functional analysis.
  • Microbial Strain Characterization Fast and affordable microbial strain characterization services to explore microbial diversity, functionality, and applications with regulatory report generation.
  • Marker Gene Analysis Sequencing service for analyzing specific marker genes in microbial communities.
  • Microbiome Profiling Service for profiling the taxonomic composition of microbial communities.
  • Absolute Abundance Quantitative microbiome profiling service for measuring the absolute abundance of microbial taxa.
  • Direct-to-Consumer Testing Consumer-facing microbiome testing services that provide personalized health insights.
  • Metabolomics Services Comprehensive metabolomics services including both untargeted and targeted metabolomics analyses, integrated with metagenomics and other omics data to reveal functional potential and health outcomes.
  • Metatranscriptomics and Transcriptomics Services RNA sequencing services for gene expression profiling, active metabolic pathway discovery, and understanding microbial responses under various conditions.
  • Proteomics Services Protein analysis services supporting microbiome research.
  • Metaproteomics Service for analyzing protein expression in complex microbial communities.
  • Bacterial Genome Sequencing 16S rRNA sequencing service for accurate bacterial identification.
  • Sampling Kits and Project Handling Custom kits and project handling for efficient microbiome sample collection, preservation, and transport, tailored to study needs and global logistics.
  • Biostatistics Statistical analysis services for microbiome and multi-omics research data.
  • Integrative Systems Biology and Multi-omics Services Integrative analysis combining multi-omics data (metagenomics, metabolomics, transcriptomics, proteomics, epigenomics) with advanced bioinformatics to deliver actionable insights.
  • Strain Tracking and Engraftment Service for tracking microbial strains and monitoring engraftment in microbiome studies.
  • Machine Learning and AI Services AI-powered bioinformatics services for analyzing complex microbiome and multi-omics data.

Quantifiable outcome

  • Minimizing false positives through robust pipelines and quality controls
  • +1 more outcomes

Companies that use DNASense

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles3 records

DNASense technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

DNASense partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • CosmosIDcoreStrategic or Co-development PartnerCosmosID is one of the four entities (along with Clinical Microbiomics, DNASense, and MS-Omics) that fused to form Cmbio, creating a comprehensive multi-omics research platform. CosmosID contributed its microbiome analysis expertise and Cosmos-HUB bioinformatics platform.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

DNASense competitors and assessment

Company assessment

Direct peers

  • CosmosID: CosmosID is one of the four entities that merged to form Cmbio, and its Cosmos-HUB bioinformatics platform is now a core Cmbio asset. As a historical independent, it was a direct competitor in microbiome analytics and bioinformatics software.
  • Zymo Research: Zymo Research provides both microbiome kits/consumables and a microbiome sequencing services arm (ZymoBIOMICS), competing directly with Cmbio on sample collection, sequencing, and bioinformatics. Overlapping product/service model and customer segments.
  • Clinical Microbiomics: Clinical Microbiomics (now part of Cmbio) was a direct peer in clinical microbiome sequencing and bioinformatics services, especially for pharma and translational research clients. Pre-merger overlap with DNASense in human health microbiome work.
  • RTL Genomics: RTL Genomics (a LGC Group company) provides next-generation sequencing and bioinformatics services for microbiome, environmental, and agricultural research. Directly comparable specialty lab services model and end markets.
  • MR DNA: MR DNA (Molecular Research LP) is a contract genomics lab offering 16S, shotgun metagenomics, and bioinformatics for environmental and human microbiome studies. Competes with Cmbio on price-sensitive academic and environmental microbiome projects.
  • Diversigen (Eurofins): Diversigen, now part of Eurofins, is one of the closest direct competitors, offering shotgun metagenomics, 16S, and targeted microbiome sequencing services to academic and pharma clients globally. Highly comparable services portfolio and customer base to DNASense/Cmbio.
  • MS-Omics: MS-Omics (now part of Cmbio) specialized in mass spectrometry-based metabolomics and proteomics services. Pre-merger it was a direct peer in the metabolomics leg of Cmbio's multi-omics offering.

Emerging players

  • Second Genome: Second Genome applies microbiome sciences to drug discovery, with both discovery services and therapeutic programs. Comparable to Cmbio's translational microbiome services business, though it sits further down the value chain toward therapeutics.
  • DNAnexus: DNAnexus provides cloud-based bioinformatics platforms for multi-omics data analysis, including microbiome and clinical genomics. Comparable to Cosmos-HUB as a cloud bioinformatics layer serving research and clinical customers.

Broad incumbents

  • Qiagen (CLC Bio): Qiagen offers broad bioinformatics platforms (CLC Genomics Workbench) and microbiome sample-to-insight workflows that overlap with Cosmos-HUB. Larger incumbent with broader portfolio but less specialized in pure microbiome services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

DNASense social profiles

Digital presence

DNASense financial estimates

Financial estimate

Revenue estimate

Valuation estimate

DNASense leadership team

Management profile

Number of profiles

DNASense funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

DNASense M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DNASense

What does DNASense do?

DNASense provides end-to-end microbiome and multi-omics research services built on DNA sequencing, including shotgun and long-read metagenomics, microbial strain characterization, metabolomics, metatranscriptomics, and proteomics. The company complements laboratory services with the Cosmos-HUB cloud-based bioinformatics platform and AI-driven data analysis for researchers and science-driven companies in human health, animal health, and environmental applications.

Is DNASense a public or private company?

DNASense is a private company. It is classified as unknown and is currently operating.

When was DNASense founded?

DNASense was founded in 2014. It employs 11 to 50 people.

Where is DNASense based?

DNASense is headquartered in Aalborg, Denmark, in the Europe region.

How does DNASense make money?

One revenue line is on record: laboratory Services.

Who are DNASense's main competitors?

Direct peers on record are CosmosID, Zymo Research, Clinical Microbiomics, RTL Genomics, MR DNA, Diversigen (Eurofins) and MS-Omics. Emerging players are Second Genome and DNAnexus. Qiagen (CLC Bio) is listed as a broad incumbent.

Does DNASense have an API?

No public API is recorded for DNASense.

What industry is DNASense in?

DNASense's product category is Microbiome and Multi-Omics Research Services. Its primary akta.pro industry code is HLAGANAH, Microbiome & Metagenomics Services, with a secondary code of HLAGANAI, Bioinformatics, Multi-Omics Data Analysis & Interpretation Services. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals